Evidence map›Paper›PMID 40705669›Full record

ReviewToxicological sciences : an official journal of the Society of Toxicology2025

Chemosensory tobacco product toxicology part 2: toxicological testing, assays, and state of the science.

Weihong Lin, Thomas Hill, Andrea M Stroup, Samantha Emma Sarles, Tatsuya Ogura, Farhan Augustine, Sean O'Sullivan, Irfan Rahman, Risa Robinson, Sairam V Jabba and 2 more

Abstract readReview
In one paragraph

Review in Toxicological sciences : an official journal of the Society of Toxicology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Weihong LinDepartment of Biological Sciences, University of Maryland Baltimore County, Baltimore, MD 21250, United States.ORCID 0000-0002-5828-8487
Thomas HillDivision of Nonclinical Science, Center for Tobacco Products, U.S. Food and Drug Administration, Silver Spring, MD 20993, United States.ORCID 0000-0002-7507-7331
Andrea M StroupBehavioral Health and Health Policy Practice, Westat, Rockville, MD 20850, United States.ORCID 0000-0003-2895-460X
Samantha Emma SarlesBiomedical and Chemical Engineering PhD Program, Rochester Institute of Technology, Rochester, NY 14623-5603, United States.ORCID 0000-0003-4890-1820
Tatsuya OguraDepartment of Biological Sciences, University of Maryland Baltimore County, Baltimore, MD 21250, United States.ORCID 0000-0002-6254-2337
Farhan AugustineDepartment of Chemistry and Biochemistry, University of Maryland Baltimore County, Baltimore, MD 21250, United States.ORCID 0000-0002-8348-6039
Sean O'SullivanDepartment of Biological Sciences, University of Maryland Baltimore County, Baltimore, MD 21250, United States.ORCID 0009-0004-1388-2783
Irfan RahmanDepartment of Environmental Medicine, University of Rochester Medical Center, Rochester, NY 14642, United States.ORCID 0000-0003-2274-2454
Risa RobinsonDepartment of Mechanical Engineering, Kate Gleason College of Engineering, Rochester Institute of Technology, Rochester, NY 14623, United States.ORCID 0000-0001-8488-5448
Sairam V JabbaDepartment of Anesthesiology, Center for Translational Pain Medicine (CTPM), Duke University School of Medicine, Durham, NC 27710, United States.ORCID 0000-0003-0646-3519
Caleb NussDepartment of Biomedical Engineering, Rochester Institute of Technology, Rochester, NY 14623, United States.ORCID 0009-0001-6456-5751
Edward HenselDepartment of Mechanical Engineering, Kate Gleason College of Engineering, Rochester Institute of Technology, Rochester, NY 14623, United States.ORCID 0000-0002-2682-0766

Funding

Yale Center for the Study of Tobacco Product Use and Addiction (YCSTP) Project 2: Addictive Threshold of Nicotine and the Impact of SweetenersU54DA036151 · NIDA · YALE UNIVERSITY · PI LISA M FUCITO · 2018 to 2026
$41.6M
Leadership and Logistics CoreU54DA046060 · NIDA · WESTAT, INC. · PI Andrea M Stroup · 2018 to 2026
$28.1M
WNY Center for Research on Flavored Tobacco Products (CRoFT)U54CA228110 · NCI · ROSWELL PARK CANCER INSTITUTE CORP · PI BANSAL-TRAVERS, MAANSI · 2018 to 2022
$19.8M
Developing Evidence To Inform Regulatory Policy On Nicotine Content In E-LiquidsR01DA057687 · NIDA · ROCHESTER INSTITUTE OF TECHNOLOGY · PI Risa Jean Robinson · 2024 to 2026
$2.2M
Compensatory Behavior of E-cig Users in response to Reduced Nicotine E-liquidsR21DA050852 · NIDA · ROCHESTER INSTITUTE OF TECHNOLOGY · PI ROBINSON, RISA JEAN · 2020 to 2021
$403k
Accelerated Translational Incubator Pilot ProgramCenter for Coordination of Analytics, Science, Enhancement and LogisticsHHSInstitute for Clinical and Translational ResearchNational Institute of Drug AbuseNCI NIH HHS U54 CA228110NIDA NIH HHS R01 DA057687NIDA NIH HHS R21 DA050852NIDA NIH HHS U54 DA036151NIDA NIH HHS U54 DA046060NIH HHS 1R01DA057687NIH HHS 1R21DA050852-01NIH HHS U54CA228110NIH HHS U54DA036151NIH HHS U54DA046060Tobacco Regulatory Science Toxicity Special Interest Group U54DA046060University of Maryland BaltimoreUS Food and Drug AdministrationU.S. Food and Drug Administration's Center for Tobacco Products
6 · The paper itself

Abstract

The toxicologic impacts on the normative function of the chemosensory system and the loss of its contribution to organism protection and homeostasis remain an underrepresented area of interest in the published literature. The impact of chemical constituents in electronic nicotine delivery system e-liquids or aerosols on the chemosensory system is even less known, as are the effects on product selection and use behavior-and this may be an overlooked impact on the public health. This review is a snapshot of the current state of the science and opportunities for improving and increasing the volume of publications in chemosensory toxicology on the potential impacts of tobacco products. The proposed solutions rely on the determination of the scientific community to take advantage of an unexplored field of opportunity. Active research engagement and use of an integrative, risk-driven planning framework to address harmonization and data gaps in neurosensory research programs would support harmonization, improve scientific visibility in the published literature, and recruit additional investigators to this research community.

Indexed as

Tobacco ProductsToxicity TestsToxicologyAerosolsElectronic Nicotine Delivery SystemsHumansSmellTaste PerceptionToxicological PhenomenaAerosolschemesthesischemosensoryENDS aerosol constituentssmelltastetoxicology

Identifiers

PMID40705669
PMCPMC12466322

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.